Smoking Cessation clinical trials
Access comprehensive clinical trial information for Smoking Cessation through Pure Global AI's free database. This collection includes 523 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 68 trials are actively recruiting participants.
Research for Smoking Cessation is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include The University of Hong Kong and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 523 clinical trials studying Smoking Cessation, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include The University of Hong Kong, Pfizer, Yale University, among others.